Periostin anticorps (full length)
-
- Antigène Voir toutes Periostin (POSTN) Anticorps
- Periostin (POSTN)
-
Épitope
- full length
-
Reactivité
- Humain, Souris
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp Periostin est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Specificité
- Recognizes human and mouse periostin.
- Réactivité croisée
- Humain, Souris
- Purification
- Purified from concentrated hybridoma tissue culture supernatant.
- Pureté
- >95 % (SDS-PAGE)
- Immunogène
- Full-length human periostin.
- Clone
- Stiny-1
- Isotype
- IgG1
- Top Product
- Discover our top product POSTN Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- In PBS containing 10 % glycerol and 0.02 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
-
Short Term Storage: +4°C
Long Term Storage: -20°C
Stable for at least 1 year after receipt when stored at -20°C. - Date de péremption
- 12 months
-
-
Periostin contributes to the acquisition of multipotent stem cell-like properties in human mammary epithelial cells and breast cancer cells." dans: PLoS ONE, Vol. 8, Issue 8, pp. e72962, (2013) (PubMed).
: "The perivascular niche regulates breast tumour dormancy." dans: Nature cell biology, Vol. 15, Issue 7, pp. 807-17, (2013) (PubMed).
: "
-
Periostin contributes to the acquisition of multipotent stem cell-like properties in human mammary epithelial cells and breast cancer cells." dans: PLoS ONE, Vol. 8, Issue 8, pp. e72962, (2013) (PubMed).
-
- Antigène
- Periostin (POSTN)
- Autre désignation
- Periostin (POSTN Produits)
- Synonymes
- anticorps fa99h07, anticorps pn, anticorps postn, anticorps wu:fa99h07, anticorps wu:fc70f09, anticorps zgc:153873, anticorps LOC100008945, anticorps osf-2, anticorps pdlpostn, anticorps periostin, anticorps OSF-2, anticorps OSF2, anticorps PDLPOSTN, anticorps PN, anticorps RP11-412K4.1, anticorps A630052E07Rik, anticorps AI747096, anticorps Osf2, anticorps PLF, anticorps peri, anticorps Plf, anticorps periostin, anticorps periostin, osteoblast specific factor b, anticorps periostin, osteoblast specific factor, anticorps POSTN, anticorps postnb, anticorps postn, anticorps Postn
- Sujet
- Periostin is a 90- kDa matricellular protein that consists of a typical signal sequence, followed by a cysteine-rich region, an EMI domain (protein-protein interactions), four tandem fasciclin-like domains that are responsible for integrin binding, and a C-terminal region. Periostin was originally isolated as an osteoblast-specific factor that functions as a cell adhesion molecule for pre-osteoblasts and in osteoblast recruitment, attachment and spreading. Periostin is also involved in many fundamental biological processes such as cell proliferation, cell invasion and angiogenesis. Periostin expression is increased by both transforming growth factor beta1 (TGF-beta1) and bone morphogenetic protein 2 (BMP-2). Changes in periostin expression are commonly detected in various cancers and pre-cancerous conditions, and periostin may be involved in regulating cancer cell activities that contribute to tumorigenesis, cancer progression and metastasis. Periostin has shown to be involved in many aspects of allergic inflammation, such as eosinophil recruitment, airway remodeling, development of a Th2 phenotype and increased expression of inflammatory mediators. It is evaluated as a biomarker for bronchial asthma and airway inflammation.
- UniProt
- Q15063
-